| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents at beginning of period | NaN | NaN | 295,200 | NaN |
| Net income (loss) | -40,200 | 3,100 | -28,300 | -175,900 |
| Depreciation and amortization | 184,000 | 189,100 | 191,800 | 376,300 |
| Share-based compensation | 14,200 | 17,700 | 16,100 | 29,300 |
| Restructuring and other impairments, including goodwill | NaN | 15,800 | 600 | 2,200 |
| Gain on sale from divestitures | NaN | 0 | NaN | NaN |
| Gain on legal settlement | NaN | 0 | NaN | NaN |
| Deferred income taxes | NaN | -29,900 | -6,200 | -5,400 |
| Amortization and write-off of debt issuance costs | -3,300 | -3,000 | -3,600 | -7,700 |
| Other operating activities | 16,800 | 12,700 | 18,700 | -45,800 |
| Accounts receivable | 62,300 | 11,200 | -4,000 | -2,200 |
| Prepaid expenses | 15,200 | 300 | 5,700 | 1,500 |
| Other assets | 8,700 | -2,700 | 2,600 | -3,100 |
| Accounts payable | -14,500 | 11,100 | 15,000 | -3,300 |
| Accrued expenses and other current liabilities | -34,800 | -38,600 | 63,400 | -36,100 |
| Deferred revenues | 129,300 | 5,700 | -50,900 | 42,600 |
| Operating leases, net | -800 | -1,100 | -1,100 | -3,200 |
| Other liabilities | -2,800 | 5,500 | 100 | 3,700 |
| Net cash provided by operating activities | 134,700 | 159,900 | 181,100 | 287,500 |
| Payments to acquire businesses, net of cash acquired | NaN | 0 | 0 | 0 |
| Proceeds from divestitures, net of cash divested | NaN | 0 | 0 | 0 |
| Capital expenditures | 55,800 | 70,700 | 65,600 | 126,900 |
| Net cash used for investing activities | -55,800 | -70,700 | -65,600 | -126,900 |
| Principal payments on debt | 138,500 | 0 | 100,000 | 500,000 |
| Cash dividends on preferred shares | NaN | 0 | 0 | 0 |
| Proceeds from issuance of debt | NaN | 0 | 0 | 500,000 |
| Payment of debt issuance costs, extinguishment costs, and related fees | NaN | NaN | 1,000 | 8,500 |
| Payment of debt issuance and extinguishment costs | NaN | -9,400 | NaN | NaN |
| Payments for repurchase of equity | 18,100 | 75,000 | 50,000 | 99,500 |
| Payments related to tax withholding for share-based compensation | 5,300 | 800 | 1,500 | 8,100 |
| Other financing activities | -400 | -2,200 | -2,200 | 5,600 |
| Net cash used for financing activities | -162,300 | -77,900 | -154,700 | -110,500 |
| Effects of exchange rates | -3,600 | -800 | -4,700 | 17,300 |
| Net change in cash and cash equivalents, including restricted cash | -87,000 | 10,500 | -43,900 | 67,400 |
| Cash and cash equivalents, including restricted cash, beginning of period | 329,200 | 318,700 | NaN | NaN |
| Cash and cash equivalents at end of period | NaN | NaN | 318,700 | NaN |
| Cash and cash equivalents, including restricted cash, end of period | 242,200 | 329,200 | NaN | NaN |
CLARIVATE PLC (CLVT)
CLARIVATE PLC (CLVT)